ZA933086B - Novel method of treatment of Parkinson's disease - Google Patents

Novel method of treatment of Parkinson's disease

Info

Publication number: ZA933086B
Authority: ZA; South Africa
Prior art keywords: parkinson; disease; treatment; novel method; remacemide
Prior art date: 1992-05-02

Application number

ZA933086A

Other languages

English (en)

Inventor

Peter Johnson

Barry Ernest Watkins

Eric William Harris

Original Assignee

Fisons Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-02

Filing date

1993-04-30

Publication date

1993-11-01

1993-04-30 Application filed by Fisons Corp filed Critical Fisons Corp

1993-11-01 Publication of ZA933086B publication Critical patent/ZA933086B/xx

Links

208000018737 Parkinson disease Diseases 0.000 title abstract 2
YSGASDXSLKIKOD-UHFFFAOYSA-N 2-amino-N-(1,2-diphenylpropan-2-yl)acetamide Chemical compound C=1C=CC=CC=1C(C)(NC(=O)CN)CC1=CC=CC=C1 YSGASDXSLKIKOD-UHFFFAOYSA-N 0.000 abstract 2
WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
229950000659 remacemide Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

ZA933086A 1992-05-02 1993-04-30 Novel method of treatment of Parkinson's disease ZA933086B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929209599A GB9209599D0 (en)	1992-05-02	1992-05-02	Novel therapy for the treatment of parkinsons disease

Publications (1)

Publication Number	Publication Date
ZA933086B true ZA933086B (en)	1993-11-01

Family

ID=10714969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA933086A ZA933086B (en)	1992-05-02	1993-04-30	Novel method of treatment of Parkinson's disease

Country Status (16)

Country	Link
EP (1)	EP0637956B1 (ja)
JP (1)	JP3542801B2 (ja)
KR (1)	KR950701216A (ja)
AT (1)	ATE181669T1 (ja)
CA (1)	CA2134783C (ja)
DE (1)	DE69325512T2 (ja)
DK (1)	DK0637956T3 (ja)
ES (1)	ES2135476T3 (ja)
GB (1)	GB9209599D0 (ja)
GR (1)	GR3031320T3 (ja)
HU (1)	HU211305A9 (ja)
IL (1)	IL105569A (ja)
NZ (2)	NZ299042A (ja)
SG (1)	SG49202A1 (ja)
WO (1)	WO1993021910A1 (ja)
ZA (1)	ZA933086B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025369A (en) *	1996-05-03	2000-02-15	The Board Of Regents Of The University Nebraska	N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
RU2170576C1 (ru) *	1999-11-15	2001-07-20	Государственное учреждение науки Институт токсикологии	Гидрохлориды замещенных ацетиленовых аминоспиртов, обладающие антигалоперидоловой активностью
EP2316468A1 (en)	2002-02-22	2011-05-04	Shire LLC	Delivery system and methods for protecting and administering dextroamphetamine
AU2007346591A1 (en)	2007-02-07	2008-08-14	Gosforth Centre (Holdings) Pty Ltd	Treatment of ADHD
MX2011001384A (es)	2008-08-06	2011-09-27	Gosforth Ct Holdings Pty Ltd	Composiciones y metodos para tratar trastornos psiquiatricos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA908490B (en) *	1989-10-27	1991-07-31	Fisons Corp	Use of arylalkylamides in the treatment of neurodegenerative diseases
DE3940410A1 (de) *	1989-12-04	1991-06-06	Schering Ag	Neue verwendung von nmda-rezeptor-antagonisten

1992
- 1992-05-02 GB GB929209599A patent/GB9209599D0/en active Pending
1993
- 1993-04-30 DK DK93911903T patent/DK0637956T3/da active
- 1993-04-30 WO PCT/GB1993/000908 patent/WO1993021910A1/en not_active Ceased
- 1993-04-30 CA CA002134783A patent/CA2134783C/en not_active Expired - Fee Related
- 1993-04-30 SG SG1996007583A patent/SG49202A1/en unknown
- 1993-04-30 NZ NZ299042A patent/NZ299042A/en not_active IP Right Cessation
- 1993-04-30 AT AT93911903T patent/ATE181669T1/de not_active IP Right Cessation
- 1993-04-30 JP JP51908793A patent/JP3542801B2/ja not_active Expired - Fee Related
- 1993-04-30 DE DE69325512T patent/DE69325512T2/de not_active Expired - Fee Related
- 1993-04-30 EP EP93911903A patent/EP0637956B1/en not_active Expired - Lifetime
- 1993-04-30 ZA ZA933086A patent/ZA933086B/xx unknown
- 1993-04-30 KR KR1019940703908A patent/KR950701216A/ko not_active Ceased
- 1993-04-30 IL IL105569A patent/IL105569A/xx not_active IP Right Cessation
- 1993-04-30 ES ES93911903T patent/ES2135476T3/es not_active Expired - Lifetime
- 1993-04-30 NZ NZ252728A patent/NZ252728A/en not_active IP Right Cessation
1995
- 1995-06-23 HU HU95P/P00425P patent/HU211305A9/hu unknown
1999
- 1999-09-23 GR GR990402420T patent/GR3031320T3/el unknown

Also Published As

Publication number	Publication date
GR3031320T3 (en)	1999-12-31
ATE181669T1 (de)	1999-07-15
EP0637956B1 (en)	1999-06-30
IL105569A (en)	1997-11-20
NZ299042A (en)	2000-07-28
NZ252728A (en)	1996-11-26
DE69325512D1 (de)	1999-08-05
CA2134783C (en)	2002-08-13
CA2134783A1 (en)	1993-11-11
SG49202A1 (en)	1998-05-18
WO1993021910A1 (en)	1993-11-11
JP3542801B2 (ja)	2004-07-14
EP0637956A1 (en)	1995-02-15
GB9209599D0 (en)	1992-06-17
DK0637956T3 (da)	1999-11-22
HU211305A9 (en)	1995-11-28
DE69325512T2 (de)	1999-12-16
KR950701216A (ko)	1995-03-23
JPH07506105A (ja)	1995-07-06
IL105569A0 (en)	1993-08-18
ES2135476T3 (es)	1999-11-01

Similar Documents

Publication	Publication Date	Title
PL309596A1 (en)	1995-10-30	Application of anticonvulsant agents in treating parkinson disease and parkinsonian syndromes
NZ334124A (en)	2000-10-27	Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
ID28003A (id)	2001-05-03	Turunan-turunan adamantana
GB2288732B (en)	1998-04-29	Pharmaceutical compositions
FR2735475B1 (fr)	1997-07-11	Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
ZA933086B (en)	1993-11-01	Novel method of treatment of Parkinson's disease
CA2217513A1 (en)	1996-10-10	Pharmaceutical agents for the treatment of alzheimer's disease
ITMI910658A0 (it)	1991-03-12	N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
HUT71838A (en)	1996-02-28	Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
NZ268039A (en)	1999-06-29	Use of efaroxan in treating parkinson's disease
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
CA2170289A1 (en)	1995-03-16	A method of treating liver disease and like indications with vasodilating agents
RU96118559A (ru)	1999-01-10	Лекарственное средство
FR2700115B1 (fr)	1995-02-03	Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
ITBO930460A0 (it)	1993-11-12	Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
IT1275987B1 (it)	1997-10-24	Composizione farmaceutica attiva nella cura di affezioni dermatologiche
ZA969968B (en)	1997-06-13	Use of 2-iminobenzothiazolines in the treatment of parkinson's disease and parkinsonian syndromes
TH29708A (th)	1998-08-30	เบนซิลเอมีนที่มีการเข้าแทนที่และการใช้เพื่อการรักษาโรคซึมเศร้า
TH18617B (th)	2005-06-10	เบนซิลเอมีนที่มีการเข้าแทนที่และการใช้เพื่อการรักษาโรคซึมเศร้า